Related Experiment Video
Updated: Sep 10, 2025
Evaluation of Respiratory System Mechanics in Mice using the Forced Oscillation Technique
Published on: May 15, 2013
Identification of mechanisms underlying ventilatory dysfunction in organophosphorus chemical warfare agent-exposed
Marilène Trancart1, Nicolas Taudon2, Mylène Penot2
1Toxicology and Chemical Risks Department, French Armed Forces Biomedical Research Institute, Brétigny-sur-Orge, France.
Abstract:
Chemical warfare nerve agents (CWNA), such as VX, pose significant threats due to their profound impact on vital physiological systems. The primary concern is the risk of respiratory failure resulting from cholinergic dysregulation, a signaling pathway crucial for ventilatory function regulation. This study aims to elucidate the key mechanisms underlying the induction of respiratory failure in mice following sub-lethal VX exposure in order to optimize therapeutic management. We evaluated candidate compounds targeting cholinergic signaling pathways associated with the CWNA poisoning toxidrome or implicated in respiratory disorders with similar symptoms (e.g., asthma or opioid overdose). The efficacy of these compounds in preventing ventilatory abnormalities induced by subcutaneous exposure to 0.9 LD50 of VX was assessed using dual-chamber plethysmography, and survival tests were conducted to confirm their therapeutic effectiveness. Among all the pathways evaluated, only the muscarinic pathway appeared to be involved, with atropine, a standard muscarinic receptor (mAChR) antagonist, which effectively preserved respiratory function by reducing VX-induced bronchoconstriction and preventing respiratory depression. Methylatropine, a peripheral mAChR antagonist that does not cross the blood-brain barrier (BBB), also limited bronchoconstriction but failed to prevent respiratory depression, suggesting that bronchoconstriction is not the primary determinant of this respiratory toxidrome. Surprisingly, tiotropium, a selective M3 mAChR antagonist that also does not cross the BBB, exhibited similar effects to those of atropine. Antagonizing muscarinic pathway overstimulation thus emerges as a key strategy for managing respiratory depression and improving survival outcomes in CWNA-poisoned individuals.
Insights
Chemical warfare nerve agents like VX cause respiratory failure via cholinergic system disruption. Antagonizing muscarinic receptors effectively restored breathing and improved survival in mice exposed to VX.
Area of Science:
- Toxicology
- Pharmacology
- Respiratory Physiology
Background:
- Chemical warfare nerve agents (CWNA), such as VX, present a significant threat due to their severe impact on physiological systems.
- Respiratory failure, driven by cholinergic dysregulation affecting ventilation, is a primary concern in CWNA poisoning.
- Understanding the mechanisms of VX-induced respiratory failure is crucial for developing effective therapeutic strategies.
Purpose of the Study:
- To investigate the mechanisms of respiratory failure induced by sub-lethal VX exposure in mice.
- To evaluate the efficacy of compounds targeting cholinergic pathways for therapeutic management of VX poisoning.
- To identify key pathways and therapeutic targets for mitigating VX-induced respiratory distress.
Main Methods:
- Mice were exposed to sub-lethal doses (0.9 LD50) of VX via subcutaneous injection.
- Ventilatory function was assessed using dual-chamber plethysmography to detect abnormalities.
- Survival tests were conducted to confirm the therapeutic effectiveness of candidate compounds.
- Candidate compounds targeting cholinergic signaling pathways, including muscarinic receptor antagonists, were evaluated.
Main Results:
- Only the muscarinic pathway was implicated in VX-induced respiratory failure.
- Atropine, a muscarinic receptor antagonist, preserved respiratory function by reducing bronchoconstriction and preventing respiratory depression.
- Methylatropine, a peripheral antagonist, reduced bronchoconstriction but did not prevent respiratory depression, indicating central mechanisms are key.
- Tiotropium, a selective M3 antagonist, showed effects similar to atropine, suggesting M3 receptor involvement.
Conclusions:
- Muscarinic pathway overstimulation is central to VX-induced respiratory failure.
- Antagonizing muscarinic receptors is a promising therapeutic strategy for managing respiratory depression and improving survival in CWNA poisoning.
- Targeting specific muscarinic pathways may offer optimized treatment for nerve agent exposure.
Related Concept Videos
01:26Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
01:36Types of Toxins
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...